| Molecular mimicry between Anoctamin 2 and Epstein-Barr virus nuclear antigen 1 associates with multiple sclerosis risk K Tengvall, J Huang, C Hellström, P Kammer, M Biström, B Ayoglu, ... Proceedings of the National Academy of Sciences 116 (34), 16955-16960, 2019 | 188 | 2019 |
| Increased serological response against human herpesvirus 6A is associated with risk for multiple sclerosis E Engdahl, R Gustafsson, J Huang, M Biström, I Lima Bomfim, P Stridh, ... Frontiers in Immunology 10, 2715, 2019 | 86 | 2019 |
| Vitamin D and axonal injury in multiple sclerosis L Sandberg, M Biström, J Salzer, M Vågberg, A Svenningsson, ... Multiple Sclerosis Journal 22 (8), 1027-1031, 2016 | 68 | 2016 |
| Epstein–Barr virus infection after adolescence and human herpesvirus 6A as risk factors for multiple sclerosis M Biström, D Jons, E Engdahl, R Gustafsson, J Huang, N Brenner, J Butt, ... European journal of neurology 28 (2), 579-586, 2021 | 57 | 2021 |
| Cytomegalovirus seropositivity is associated with reduced risk of multiple sclerosis—A presymptomatic case–control study V Grut, M Biström, J Salzer, P Stridh, D Jons, R Gustafsson, ... European journal of neurology 28 (9), 3072-3079, 2021 | 44 | 2021 |
| Vitamin D and multiple sclerosis: where do we go from here? J Salzer, M Biström, P Sundström Expert review of neurotherapeutics 14 (1), 9-18, 2014 | 28 | 2014 |
| Leptin levels are associated with multiple sclerosis risk M Biström, J Hultdin, O Andersen, L Alonso-Magdalena, D Jons, ... Multiple Sclerosis Journal 27 (1), 19-27, 2021 | 26 | 2021 |
| High serum concentration of vitamin D may protect against multiple sclerosis M Biström, L Alonso-Magdalena, O Andersen, D Jons, M Gunnarsson, ... Multiple Sclerosis Journal–Experimental, Translational and Clinical 5 (4 …, 2019 | 21 | 2019 |
| Human herpesvirus 6A and axonal injury before the clinical onset of multiple sclerosis V Grut, M Biström, J Salzer, P Stridh, D Jons, R Gustafsson, ... Brain 147 (1), 177-185, 2024 | 12 | 2024 |
| Axonal injury in asymptomatic individuals preceding onset of multiple sclerosis D Jons, H Zetterberg, M Biström, L Alonso‐Magdalena, M Gunnarsson, ... Annals of Clinical and Translational Neurology 9 (6), 882-887, 2022 | 8 | 2022 |
| Systemic inflammation and risk of multiple sclerosis–A presymptomatic case-control study V Grut, M Biström, J Salzer, P Stridh, A Lindam, L Alonso-Magdalena, ... Multiple Sclerosis Journal–Experimental, Translational and Clinical 8 (4 …, 2022 | 7 | 2022 |
| Seroreactivity against lytic, latent and possible cross-reactive EBV antigens appears on average 10 years before MS induced preclinical neuroaxonal damage D Jons, V Grut, T Bergström, H Zetterberg, M Biström, M Gunnarsson, ... Journal of Neurology, Neurosurgery & Psychiatry 95 (4), 325-332, 2024 | 5 | 2024 |
| Free vitamin D3 index and vitamin D‐binding protein in multiple sclerosis: A presymptomatic case–control study V Grut, M Biström, J Salzer, P Stridh, A Lindam, L Alonso‐Magdalena, ... European Journal of Neurology 29 (8), 2335-2342, 2022 | 5 | 2022 |
| Interactions between High Seroreactivity to Human Herpes Virus 6A and Epstein–Barr Virus in MS Development: A Presymptomatic Case–Control Study V Grut, M Biström, J Salzer, P Stridh, D Jons, R Gustafsson, J Huang, ... Annals of Neurology, 2024 | 4 | 2024 |
| Increase in Epstein Barr virus serologies precedes neuroaxonal damage in pre-symptomatic multiple sclerosis D Jons, T Bergström, H Zetterberg, M Bistroem, L Alonso-Magdalena, ... Multiple Sclerosis Journal 28 (Suppl. 3), 86-87, 2022 | 2 | 2022 |
| Rubella virus seropositivity after infection or vaccination as a risk factor for multiple sclerosis J Ingvarsson, V Grut, M Biström, LP Berg, P Stridh, J Huang, J Hillert, ... European journal of neurology 31 (10), e16387, 2024 | 1 | 2024 |
| Environmental risk factors for the occurrence of multiple sclerosis M Biström Umeå universitet, 2020 | 1 | 2020 |
| Response to ‘Mendelian randomization analysis does not support a role for leptin in multiple sclerosis’ M Biström, J Hultdin, P Sundström Multiple Sclerosis Journal 27 (1), 161-162, 2021 | | 2021 |
| Serological response against HHV-6A is associated with increased risk for multiple sclerosis E Engdahl, R Gustafsson, J Huang, M Biström, IL Bomfim, P Stridh, ... Multiple Sclerosis Journal 25, 81-82, 2019 | | 2019 |
| Die Post-Alemtuzumab-Therapie-induzierte Schilddrüsendysfunktion bei schubförmig-remittierender MS (RRMS)–ein variantenreiches Krankheitsbild auf einem interdisziplinären Terrain HK Goischke Aktuelle Neurologie 45 (01), 44-51, 2018 | | 2018 |
